Skip to main content
Caplight Logo









Ansana

Ansana

Private
MaastrichtHealthcare & Life Scienceshttps://ansana.health

Last Round

Seed

Sep 12, 2025

Total Funding Raised

$2.69M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ansana operates in Healthcare & Life Sciences and is based in Maastricht. Its latest recorded funding round was a Seed round in September 2025.

Ansana is a health-tech company that develops smart sterilization technology for surgical instruments to improve patient safety, efficiency, and sustainability in healthcare.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Supply Chain Tracking

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ansana Comparables

Compare Ansana with similar companies based on industry and business-model similarity.

Ansana comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caretag
86%
SpaTrack Medical Limited
83%
Zuno Medical
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ansana Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 12, 2025
SeedDec 20, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ansana Investors

Notable investors and investment history

Ansana investors
InvestorRounds
Healthliant VenturesSeed
LIOFSeed
BGO VenturesSeed
NLC Health VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 2529% MoM, reaching 2.6K.

  • Jul 25, 2026

    Monthly visitors grew 669% MoM, from 13 to 100.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ansana Filings

Explore SEC and related filing metadata, where available.

Ansana filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ansana's valuation, stock price, and market status.

Is Ansana a public or private company?

Ansana is a private company.

What is the current stock price of Ansana?

Ansana is a private company, so its shares have no public market price. Caplight tracks Ansana's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ansana worth (valuation)?

Valuation information for Ansana is not publicly available.

Can I buy Ansana stock?

Ansana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ansana's last funding round?

Ansana's most recent funding round was Seed on September 12, 2025.

Who are the main investors in Ansana?

Key investors in Ansana include Healthliant Ventures, NLC Health Ventures.

Will Ansana IPO soon?

No public IPO plans have been announced for Ansana.

How can I track Ansana secondary market activity?

Caplight tracks bids, offers, and trades in Ansana's shares on secondary markets.

Firmographic Details

HeadquartersMaastricht
Employee Range8
Year Founded2023
Last FundingSep 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?